Cairn Investment Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Sell |
8,274
-82
| -1% | -$10.3K | 0.54% | 39 |
|
|
2025
Q1 | $1.14M | Sell |
8,356
-7
| -0.1% | -$958 | 0.65% | 36 |
|
|
2024
Q4 | $1.28M | Sell |
8,363
-3,153
| -27% | -$482K | 0.75% | 36 |
|
|
2024
Q3 | $2.23M | Buy |
11,516
+366
| +3% | +$70.9K | 1.23% | 27 |
|
|
2024
Q2 | $2.59M | Sell |
11,150
-183
| -2% | -$42.4K | 1.51% | 27 |
|
|
2024
Q1 | $2.44M | Buy |
11,333
+207
| +2% | +$44.6K | 1.4% | 25 |
|
|
2023
Q4 | $2.88M | Buy |
11,126
+323
| +3% | +$83.6K | 1.8% | 20 |
|
|
2023
Q3 | $2.78M | Buy |
10,803
+622
| +6% | +$160K | 1.84% | 20 |
|
|
2023
Q2 | $2.9M | Buy |
10,181
+361
| +4% | +$103K | 1.88% | 21 |
|
|
2023
Q1 | $2.73M | Buy |
9,820
+255
| +3% | +$70.9K | 1.9% | 19 |
|
|
2022
Q4 | $2.65M | Buy |
9,565
+445
| +5% | +$123K | 1.97% | 16 |
|
|
2022
Q3 | $2.44M | Sell |
9,120
-90
| -1% | -$24K | 1.97% | 15 |
|
|
2022
Q2 | $1.88M | Buy |
9,210
+100
| +1% | +$20.4K | 1.46% | 25 |
|
|
2022
Q1 | $2.03M | Buy |
9,110
+1,260
| +16% | +$281K | 1.29% | 29 |
|
|
2021
Q4 | $1.88M | Buy |
7,850
+600
| +8% | +$144K | 1.3% | 28 |
|
|
2021
Q3 | $2.05M | Buy |
7,250
+113
| +2% | +$32K | 1.52% | 21 |
|
|
2021
Q2 | $2.47M | Buy |
7,137
+175
| +3% | +$60.6K | 1.81% | 12 |
|
|
2021
Q1 | $1.95M | Sell |
6,962
-130
| -2% | -$36.4K | 1.62% | 19 |
|
|
2020
Q4 | $1.74M | Buy |
7,092
+82
| +1% | +$20.1K | 1.64% | 24 |
|
|
2020
Q3 | $1.99M | Buy |
7,010
+5,835
| +497% | +$1.65M | 2.11% | 16 |
|
|
2020
Q2 | $314K | Sell |
1,175
-55
| -4% | -$14.7K | 0.38% | 61 |
|
|
2020
Q1 | $389K | Sell |
1,230
-200
| -14% | -$63.3K | 0.58% | 52 |
|
|
2019
Q4 | $424K | Buy |
+1,430
| New | +$424K | 0.42% | 69 |
|